Probiotics in the Management of Colonic Disorders

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2007 Nov 10

PMID 17991347

Citations 7

Authors

Eamonn M M Quigley

Affiliations

Soon will be listed here.

Abstract

Probiotics have been used in humans for almost a century and widely recommended for the treatment of a variety of ills assumed to be of colonic origin, including diarrhea, constipation, bloating, and flatulence. More recently, probiotics have been evaluated in the management of specific colonic disorders such as inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile colitis. It is evident that no two probiotics are exactly alike; why then should we expect reproducible results from studies that employ different species or strains, variable formulations, and diverse dosing schedules? When probiotics have been studied with the rigor appropriate to a new therapeutic modality, some coherent results have emerged: specific strains are effective in certain diarrheal states, irritable bowel syndrome, ulcerative colitis, and pouchitis, as well as in the prevention of C. difficile-related colitis. Even here, not to mention other colonic disorders, further adequately powered and appropriately designed trials are needed.

Citing Articles

New strategies for the management of diverticular disease: insights for the clinician.

Boynton W, Floch M Therap Adv Gastroenterol. 2013; 6(3):205-13.

PMID: 23634185 PMC: 3625022. DOI: 10.1177/1756283X13478679.

Quantitative real time PCR detection of Clostridium difficile growth inhibition by probiotic organisms.

Folkers B, Schuring C, Essmann M, Larsen B N Am J Med Sci. 2012; 2(1):5-10.

PMID: 22624106 PMC: 3354390. DOI: 10.4297/najms.2010.15.

Diverticular disease: A therapeutic overview.

Tursi A World J Gastrointest Pharmacol Ther. 2011; 1(1):27-35.

PMID: 21577292 PMC: 3091143. DOI: 10.4292/wjgpt.v1.i1.27.

Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.

Tursi A, Joseph R, Streck P Dig Dis Sci. 2011; 56(11):3112-21.

PMID: 21567193 DOI: 10.1007/s10620-011-1731-x.

Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to....

Click R Virulence. 2011; 2(2):131-43.

PMID: 21460639 PMC: 3265756. DOI: 10.4161/viru.2.2.15647.

References

Amenta M, Cascio M, Di Fiore P, Venturini I . Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight). Acta Biomed. 2007; 77(3):157-62. View

Guarner F, Malagelada J . Gut flora in health and disease. Lancet. 2003; 361(9356):512-9. DOI: 10.1016/S0140-6736(03)12489-0. View

Rembacken B, Snelling A, Hawkey P, Chalmers D, Axon A . Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999; 354(9179):635-9. DOI: 10.1016/s0140-6736(98)06343-0. View

Shanahan F . The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol. 2002; 16(6):915-31. DOI: 10.1053/bega.2002.0342. View

Ewaschuk J, Tejpar Q, Soo I, Madsen K, Fedorak R . The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep. 2006; 8(6):486-98. DOI: 10.1007/s11894-006-0039-z. View

Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A . Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004; 20(10):1133-41. DOI: 10.1111/j.1365-2036.2004.02268.x. View

Szajewska H, Skorka A, Dylag M . Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007; 25(3):257-64. DOI: 10.1111/j.1365-2036.2006.03202.x. View

Michail S, Sylvester F, Fuchs G, Issenman R . Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr. 2006; 43(4):550-7. DOI: 10.1097/01.mpg.0000239990.35517.bf. View

Wullt M, Hagslatt M, Odenholt I . Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis. 2003; 35(6-7):365-7. DOI: 10.1080/00365540310010985. View

10.

Bibiloni R, Fedorak R, Tannock G, Madsen K, Gionchetti P, Campieri M . VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005; 100(7):1539-46. DOI: 10.1111/j.1572-0241.2005.41794.x. View

11.

Whorwell P, Altringer L, Morel J, Bond Y, Charbonneau D, OMahony L . Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006; 101(7):1581-90. DOI: 10.1111/j.1572-0241.2006.00734.x. View

12.

Gupta P, Andrew H, Kirschner B, Guandalini S . Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr. 2000; 31(4):453-7. DOI: 10.1097/00005176-200010000-00024. View

13.

Floch M . A hypothesis: is diverticulitis a type of inflammatory bowel disease?. J Clin Gastroenterol. 2006; 40 Suppl 3:S121-5. DOI: 10.1097/01.mcg.0000225502.29498.ba. View

14.

Banaszkiewicz A, Szajewska H . Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr. 2005; 146(3):364-9. DOI: 10.1016/j.jpeds.2004.10.022. View

15.

McFarland L . Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007; 5(2):97-105. DOI: 10.1016/j.tmaid.2005.10.003. View

16.

Zocco M, Zileri Dal Verme L, Cremonini F, Piscaglia A, Nista E, Candelli M . Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 2006; 23(11):1567-74. DOI: 10.1111/j.1365-2036.2006.02927.x. View

17.

Quigley E . Germs, gas and the gut; the evolving role of the enteric flora in IBS. Am J Gastroenterol. 2006; 101(2):334-5. DOI: 10.1111/j.1572-0241.2006.00445.x. View

18.

Roberfroid M . Prebiotics: the concept revisited. J Nutr. 2007; 137(3 Suppl 2):830S-7S. DOI: 10.1093/jn/137.3.830S. View

19.

Urbancsek H, Kazar T, Mezes I, Neumann K . Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001; 13(4):391-6. DOI: 10.1097/00042737-200104000-00015. View

20.

Guslandi M, Giollo P, Testoni P . A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003; 15(6):697-8. DOI: 10.1097/00042737-200306000-00017. View